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AK 9,503 66.5 15.2 44.1 253 58 11.6 23.5
AL 219,195 1,341.8 31.4 51.3 213 53 10.0 22.0
AR 122,360 841.7 29.2 44.9 220 60 11.5 22.8
AZ 248,140 1,267.7 16.1 61.3 205 59 11.0 22.0
CA 1,361,923 7,250.4 19.7 59.5 240 51 12.3 21.2
CO 151,195 774.5 20.6 61.6 162 57 10.6 20.1
CT 146,278 773.1 23.2 61.2 328 71 14.4 18.0
DC 13,339 81.1 24.8 49.9 293 54 15.5 27.5
DE 43,862 193.9 27.0 73.1 314 73 12.6 18.0
FL 1,015,116 5,818.4 22.6 55.2 230 50 11.2 21.2
GA 338,455 2,175.4 29.5 47.9 248 66 11.1 23.8
HI 62,400 350.9 24.1 56.6 263 51 13.2 20.1
IA 140,477 855.3 21.7 53.5 158 55 9.4 15.2
ID 57,170 304.5 20.9 59.3 181 53 9.8 19.4
IL 422,253 2,347.4 23.2 57.8 224 62 10.9 18.7
IN 277,072 1,488.9 27.3 59.8 227 68 10.8 18.7
KS 114,316 685.3 23.9 53.3 195 61 9.6 18.9
KY 203,340 1,295.3 24.2 49.8 220 59 10.3 20.7
LA 193,882 1,302.9 29.9 46.2 291 64 11.7 23.8
MA 236,282 1,377.3 11.4 55.4 209 48 10.6 17.4
MD 179,259 856.7 25.8 66.9 271 68 12.5 19.9
ME 58,859 278.1 12.8 67.9 184 38 9.9 16.9
MI 466,703 2,181.0 23.3 68.6 167 51 9.9 18.3
MN 207,776 1,014.5 1.08 66.9 120 46 8.8 14.8
MO 265,124 1,626.1 20.8 51.8 199 54 9.9 19.4
MS 126,731 887.8 34.8 43.7 272 61 11.6 25.1
MT 37,257 208.8 19.0 57.1 157 52 9.7 17.9
NC 422,861 2,697.2 28.4 49.1 220 58 10.7 21.6
ND 28,278 165.7 21.1 55.9 165 61 9.4 14.4
NE 71,064 475.2 24.4 48.1 207 67 10.5 16.9
NH 43,291 225.5 14.7 62.5 199 58 10.5 16.4
NJ 369,018 1,922.7 29.8 61.9 400 81 14.6 19.6
NM 72,463 383.7 18.4 58.5 180 47 10.9 23.4
NV 98,516 512.4 21.6 60.8 170 43 9.1 21.6
NY 858,154 5,166.7 25.9 53.4 324 53 12.7 19.6
OH 542,703 2,947.9 24.8 59.1 198 56 10.2 18.7
OK 149,289 842.7 26.1 55.1 239 65 10.8 22.4
OR 165,874 877.9 15.1 59.9 152 50 9.7 18.6
PA 620,461 3,826.6 23.8 51.8 285 67 12.1 18.6
PR 247,800 2,158.9 27.7 35.5 173 30 13.4 28.7
RI 48,969 348 17.6 45.6 217 53 11.3 17.3
SC 216,916 1,344.4 34.2 50.1 280 68 11.9 23.0
SD 34,051 206.2 20.6 53.5 169 58 9.4 16.6
TN 300,863 1,791.0 25.4 53.0 224 57 10.6 20.9
TX 871,290 4,850.8 29.0 56.0 273 61 11.6 23.4
UT 68,682 340.6 27.5 62.8 171 59 9.5 22.3
VA 268,751 1,533.8 26.2 56.0 224 61 10.8 19.5
VI 4,388 32.9 41.6 36.2 171 78 15.7 39.7
VT 24,809 124.0 14.0 65.7 177 44 10.0 14.6
WA 223,394 1,152.9 13.1 61.6 154 49 9.5 19.1
WI 229,788 1,201.6 20.3 62.8 179 54 9.9 14.8
WV 96,231 588.1 24.7 52.2 245 58 11.0 19.6
WY 18,638 104.6 21.5 56.5 195 65 10.6 19.7
* Nonadherence is defined as patients not following their health care professional’s instructions concerning taking their prescribed medication. 
Using the proportion of days covered methodology, beneficiaries were considered nonadherent if they had access to AHM for <80% of the days
from the date of their first AHM fill through the end of 2014 or until their death in 2014. 
